Be a PRO & get up to 50% off on select brands. Explore Now

Explained | All you need to know about PLI scheme

The government in March made 53 bulk drugs eligible for a PLI worth Rs 6,940 crore. The scheme is expected to benefit up to 136 manufacturing units, generating incremental sales of Rs 46,400 crore and significant additional employment generation over the next eight years.

November 12, 2020 / 06:00 PM IST

The Union Cabinet approved the Production-Linked Incentive (PLI) scheme for 10 sectors on November 11. These are pharmaceuticals, automobiles and auto components, telecom and networking products, advanced chemistry cell battery, textile, food products, solar modules, white goods, and specialty steel.

"The PLI scheme across these 10 key specific sectors will make Indian manufacturers globally competitive, attract investment in the areas of core competency and cutting-edge technology, ensure efficiencies, create economies of scale, enhance exports, and make India an integral part of the global supply chain," according to a government statement.

What is a PLI scheme?

In order to reduce India's dependence on China, the government in March announced a scheme that aims to give companies incentives on incremental sales from products manufactured in domestic units.

The scheme is applicable for mobile and allied equipment as well as pharmaceutical ingredients and medical devices manufacturing. As these sectors are labour-intesive, it is expected to cater to the growing growing employment demands of the country.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"The Government of India is taking critical economic and fiscal measures to bring the economy back on its growth track. One of such measures is introducing and extending production linked incentive schemes in various sectors. The recently approved package will boost production, exports, forex earnings and employment," Arvind Sharma, partner, Shardul Amarchand Mangaldas & Co said.

Which sectors already have PLI scheme?

The government in March made 53 bulk drugs eligible for a PLI worth Rs 6,940 crore. The scheme is expected to benefit up to 136 manufacturing units, generating incremental sales of Rs 46,400 crore and significant additional employment generation over the next eight years.

It also announced a Rs 14,000-crore package that would incentivise production of active pharmaceutical ingredients (API) and medical devices in the country. As part of the scheme, it announced a Rs 3,420-crore PLI for promoting domestic manufacturing of medical devices.

Apart from pharmaceuticals and medicines, the government also notified a PLI scheme for electronics and mobile phone sectors in accordance with the National Policy on Electronics. As part of the scheme, incentives of 4-6 percent will be given to electronics companies that manufacture mobile phones and other electronic components such as transistors, diodes, thyristors, resistors, capacitors, and nano-electronic components such as microelectromechanical systems, in India.

Why is it necessary?

It is difficult for the government to make sustained investments in capital-intensive sectors as they have a longer gestation period, according to experts.

"The PLI scheme, since it is based on incremental output, is more effective from the government’s standpoint than some of the other grant-based schemes like Mega Food Parks, etc. which are more input oriented. It is also targeted towards the larger anchor investors who are capable of mobilising the initial investment for brownfield or greenfield projects by themselves,” according to Arindam Guha, partner, leader – government & public services, Deloitte India.

The aim of a PLI scheme is to incentivise and invite global, capital-rich companies to set up capacities in India.
Kamalika Ghosh
first published: Nov 12, 2020 06:00 pm

stay updated

Get Daily News on your Browser
Enjoying Moneycontrol?

How about a quick survey to help us improve our services?

Ok, sure

Maybe next time!